Market Trends of Intrathecal Pumps Industry
Morphine Segment is Expected to Witness Growth Over the Forecast Period
- Morphine is an analgesic and narcotic drug obtained from opium for the treatment of moderate to severe pain. Morphine extended-release tablets and capsules are only used to relieve severe pain that the use of other pain medications cannot control. The rising prevalence of chronic diseases such as arthritis, cancer, and other diseases is expected to increase the demand for morphine solutions for relieving pain. Therefore, the increasing need for pain management drugs to treat severe pain related to chronic diseases is elevating the segment's growth.
- According to the American Cancer Society, in 2021, it has been stated that the number of cancer cases is 1.9 million, and cancer deaths are around 608 thousand in the United States. And in 2022, the same source projected that the new number of cancer cases was 1.9 million and around 609 thousand cancer deaths in the United States. Hence, the increasing number of cancer cases is elevating the need for intrathecal pumps.
- Focused education programs addressing morphine misperceptions might increase patient and caregiver acceptance of opioid analgesics and improve cancer pain control. Morphine is a readily adopted pain reliever for cancer patients and survivors, propelling the segment during the study period. Therefore, the intrathecal pumps segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
Understand The Key Trends Shaping This Market
Download Sample
North America is Expected to Dominate the Intrathecal Pumps Market
- North America holds the largest share in the global intrathecal pumps market. The higher prevalence rates of cancer and chronic postoperative pain, neck pain, which facilitates the use of pain medications, is expected to drive the market growth.
- For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021, it has been stated that chronic pain affected 20.9% of United States adults, which has increased from the past year. A high number of individuals that have chronic pain is elevating the need for various pain relievers. Hence, this is going to elevate the growth of the intrathecal pumps market.
- North America spends more on healthcare needs than other regions, which is another factor contributing to market growth. For instance, in January 2021, the North American Spine Society (NASS) developed coverage recommendations on spinal intrathecal delivery systems for the treatment of chronic pain.
- Similarly, according to the North American Spine Society (NASS), the spinal intrathecal delivery system procedure may show the effect in a small group of people with chronic pain and spinal injury. This procedure can be helpful in people who have exhausted all other options to treat their symptoms. These patients should have a psychological evaluation to rule out drug and alcohol disorders and other psychological conditions. The device's ability to deliver low doses of the drug to reduce unbearable pain is one of the driving factors in market growth.
- Therefore, owing to the aforesaid factors, the growth of the studied market is anticipated in the North America Region.
Get Analysis on Important Geographic Markets
Download Sample
